_id
69130253ccc777a4e85d7995
Ticker
INTS
Name
Intensity Therapeutics, Inc. Common stock
Exchange
NASDAQ
Address
1 Enterprise Drive, Shelton, CT, United States, 06484-4779
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.intensitytherapeutics.com
Description
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.
Last Close
0.59
Volume
731508
Current Price
0.47
Change
-20.33898305084746
Last Updated
2025-12-01T09:23:04.065Z
Image
-
Ipo Date
2023-06-30T00:00:00.000Z
Market Cap
23983940
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
3.8
Target Price
2.9167
Strong Buy
1
Buy
2
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
2733000
Operating Income
-2733000
Interest Expense
-
Pretax Income
-2671000
Net Income
-2671000
Eps
-0.14156150341178594
Dividends Per Share
-
Shares Outstanding
60064965
Income Tax Expense
-
EBITDA
62000
Operating Margin
-
Total Other Income Expense Net
62000
Cash
7067000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
8186000
Property Plant Equipment
103000
Total Assets
9585000
Payables
1684000
Short Term Debt
31000
Long Term Debt
-
Total Liabilities
2363000
Equity
7222000
Depreciation
6000
Change In Working Capital
-193000
Cash From Operations
-2387000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
7238000
Net Change In Cash
4851000
PE
-
PB
1.227917236222653
ROE
-36.984214898919966
ROA
-27.86645800730308
FCF
-2387000
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
4.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
3
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
2733000
Quarters > 0 > income Statement > operating Income
-2733000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-2671000
Quarters > 0 > income Statement > net Income
-2671000
Quarters > 0 > income Statement > eps
-0.14156150341178594
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
18868124
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
62000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
62000
Quarters > 0 > balance Sheet > cash
7067000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
8186000
Quarters > 0 > balance Sheet > property Plant Equipment
103000
Quarters > 0 > balance Sheet > total Assets
9585000
Quarters > 0 > balance Sheet > payables
1684000
Quarters > 0 > balance Sheet > short Term Debt
31000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2363000
Quarters > 0 > balance Sheet > equity
7222000
Quarters > 0 > cash Flow > net Income
-2671000
Quarters > 0 > cash Flow > depreciation
6000
Quarters > 0 > cash Flow > change In Working Capital
-193000
Quarters > 0 > cash Flow > cash From Operations
-2387000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
7238000
Quarters > 0 > cash Flow > net Change In Cash
4851000
Quarters > 0 > ratios > PE
-0.14156150341178594
Quarters > 0 > ratios > PB
1.227917236222653
Quarters > 0 > ratios > ROE
-36.984214898919966
Quarters > 0 > ratios > ROA
-27.86645800730308
Quarters > 0 > ratios > FCF
-2387000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
7000
Quarters > 1 > income Statement > gross Profit
-7000
Quarters > 1 > income Statement > operating Expenses
2705000
Quarters > 1 > income Statement > operating Income
-2705000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-2537000
Quarters > 1 > income Statement > net Income
-2537000
Quarters > 1 > income Statement > eps
-0.13445957849333617
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
18868124
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2705000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
168000
Quarters > 1 > balance Sheet > cash
2216000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
3038000
Quarters > 1 > balance Sheet > property Plant Equipment
109000
Quarters > 1 > balance Sheet > total Assets
4443000
Quarters > 1 > balance Sheet > payables
1193000
Quarters > 1 > balance Sheet > short Term Debt
30000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2259000
Quarters > 1 > balance Sheet > equity
2184000
Quarters > 1 > cash Flow > net Income
-2537000
Quarters > 1 > cash Flow > depreciation
7000
Quarters > 1 > cash Flow > change In Working Capital
-570000
Quarters > 1 > cash Flow > cash From Operations
-2456000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
3743000
Quarters > 1 > cash Flow > net Change In Cash
1287000
Quarters > 1 > ratios > PE
-0.13445957849333617
Quarters > 1 > ratios > PB
4.060447930402931
Quarters > 1 > ratios > ROE
-116.16300366300368
Quarters > 1 > ratios > ROA
-57.10105784379923
Quarters > 1 > ratios > FCF
-2456000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
28
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
6000
Quarters > 2 > income Statement > gross Profit
-6000
Quarters > 2 > income Statement > operating Expenses
3394000
Quarters > 2 > income Statement > operating Income
-3394000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-3347000
Quarters > 2 > income Statement > net Income
-3347000
Quarters > 2 > income Statement > eps
-0.22058635504345953
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
15173196
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-3394000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
47000
Quarters > 2 > balance Sheet > cash
929000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1651000
Quarters > 2 > balance Sheet > property Plant Equipment
116000
Quarters > 2 > balance Sheet > total Assets
3065000
Quarters > 2 > balance Sheet > payables
1586000
Quarters > 2 > balance Sheet > short Term Debt
29000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2731000
Quarters > 2 > balance Sheet > equity
334000
Quarters > 2 > cash Flow > net Income
-3347000
Quarters > 2 > cash Flow > depreciation
6000
Quarters > 2 > cash Flow > change In Working Capital
917000
Quarters > 2 > cash Flow > cash From Operations
-1989000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
328000
Quarters > 2 > cash Flow > net Change In Cash
-1661000
Quarters > 2 > ratios > PE
-0.22058635504345953
Quarters > 2 > ratios > PB
21.35150335329341
Quarters > 2 > ratios > ROE
-1002.0958083832335
Quarters > 2 > ratios > ROA
-109.20065252854812
Quarters > 2 > ratios > FCF
-1989000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
17
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
24000
Quarters > 3 > income Statement > cost Of Revenue
12000
Quarters > 3 > income Statement > gross Profit
12000
Quarters > 3 > income Statement > operating Expenses
3203000
Quarters > 3 > income Statement > operating Income
-3203000
Quarters > 3 > income Statement > interest Expense
0
Quarters > 3 > income Statement > pretax Income
-3181000
Quarters > 3 > income Statement > net Income
-3181000
Quarters > 3 > income Statement > eps
-0.21745951773344427
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
14628010
Quarters > 3 > income Statement > income Tax Expense
37276
Quarters > 3 > income Statement > EBITDA
-3181000
Quarters > 3 > income Statement > operating Margin
-13345.833333333334
Quarters > 3 > income Statement > total Other Income Expense Net
22000
Quarters > 3 > balance Sheet > cash
2590000
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
3363000
Quarters > 3 > balance Sheet > property Plant Equipment
122000
Quarters > 3 > balance Sheet > total Assets
4783000
Quarters > 3 > balance Sheet > payables
1219000
Quarters > 3 > balance Sheet > short Term Debt
28000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1865000
Quarters > 3 > balance Sheet > equity
2918000
Quarters > 3 > cash Flow > net Income
-3181000
Quarters > 3 > cash Flow > depreciation
6000
Quarters > 3 > cash Flow > change In Working Capital
-229000
Quarters > 3 > cash Flow > cash From Operations
-2668000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-9410000
Quarters > 3 > cash Flow > cash From Financing
2476000
Quarters > 3 > cash Flow > net Change In Cash
-192000
Quarters > 3 > ratios > PE
-0.21745951773344427
Quarters > 3 > ratios > PB
2.356122241261138
Quarters > 3 > ratios > ROE
-109.01302261823167
Quarters > 3 > ratios > ROA
-66.5063767509931
Quarters > 3 > ratios > FCF
-2668000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-111.16666666666667
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
25000
Annuals > 0 > income Statement > gross Profit
-25000
Annuals > 0 > income Statement > operating Expenses
16585000
Annuals > 0 > income Statement > operating Income
-16585000
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-16268000
Annuals > 0 > income Statement > net Income
-16268000
Annuals > 0 > income Statement > eps
-1.169772890189691
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
13906973
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-16268000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
317000
Annuals > 0 > balance Sheet > cash
2590000
Annuals > 0 > balance Sheet > short Term Investments
0
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
3363000
Annuals > 0 > balance Sheet > property Plant Equipment
122000
Annuals > 0 > balance Sheet > total Assets
4783000
Annuals > 0 > balance Sheet > payables
1219000
Annuals > 0 > balance Sheet > short Term Debt
28000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1865000
Annuals > 0 > balance Sheet > equity
2918000
Annuals > 0 > cash Flow > net Income
-16268000
Annuals > 0 > cash Flow > depreciation
25000
Annuals > 0 > cash Flow > change In Working Capital
-2101000
Annuals > 0 > cash Flow > cash From Operations
-15220000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
6354000
Annuals > 0 > cash Flow > cash From Financing
2900000
Annuals > 0 > cash Flow > net Change In Cash
-5966000
Annuals > 0 > ratios > PE
-1.169772890189691
Annuals > 0 > ratios > PB
1.903034379335161
Annuals > 0 > ratios > ROE
-557.5051405071968
Annuals > 0 > ratios > ROA
-340.1212628057704
Annuals > 0 > ratios > FCF
-15220000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
147000
Annuals > 1 > income Statement > gross Profit
-147000
Annuals > 1 > income Statement > operating Expenses
8172000
Annuals > 1 > income Statement > operating Income
-8319000
Annuals > 1 > income Statement > interest Expense
305000
Annuals > 1 > income Statement > pretax Income
-10538000
Annuals > 1 > income Statement > net Income
-10538000
Annuals > 1 > income Statement > eps
-0.768670961488622
Annuals > 1 > income Statement > dividends Per Share
1324000
Annuals > 1 > income Statement > shares Outstanding
13709377
Annuals > 1 > income Statement > income Tax Expense
1
Annuals > 1 > income Statement > EBITDA
-10086000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-2219000
Annuals > 1 > balance Sheet > cash
8556000
Annuals > 1 > balance Sheet > short Term Investments
6220000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
15464000
Annuals > 1 > balance Sheet > property Plant Equipment
147000
Annuals > 1 > balance Sheet > total Assets
17295000
Annuals > 1 > balance Sheet > payables
3048000
Annuals > 1 > balance Sheet > short Term Debt
20000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
4133000
Annuals > 1 > balance Sheet > equity
13162000
Annuals > 1 > cash Flow > net Income
-10538000
Annuals > 1 > cash Flow > depreciation
147000
Annuals > 1 > cash Flow > change In Working Capital
-633000
Annuals > 1 > cash Flow > cash From Operations
-7205000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-6023000
Annuals > 1 > cash Flow > cash From Financing
20472000
Annuals > 1 > cash Flow > net Change In Cash
7244000
Annuals > 1 > ratios > PE
-0.768670961488622
Annuals > 1 > ratios > PB
0.4159059592843033
Annuals > 1 > ratios > ROE
-80.0638200881325
Annuals > 1 > ratios > ROA
-60.93090488580515
Annuals > 1 > ratios > FCF
-7205000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
179037
Annuals > 2 > income Statement > gross Profit
-179037
Annuals > 2 > income Statement > operating Expenses
7550000
Annuals > 2 > income Statement > operating Income
-7550000
Annuals > 2 > income Statement > interest Expense
81781
Annuals > 2 > income Statement > pretax Income
-7582000
Annuals > 2 > income Statement > net Income
-7582000
Annuals > 2 > income Statement > eps
-0.5788061523841935
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
13099377
Annuals > 2 > income Statement > income Tax Expense
-131908
Annuals > 2 > income Statement > EBITDA
-7500000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-32000
Annuals > 2 > balance Sheet > cash
1312000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
62304
Annuals > 2 > balance Sheet > inventories
29359
Annuals > 2 > balance Sheet > total Current Assets
1451000
Annuals > 2 > balance Sheet > property Plant Equipment
139000
Annuals > 2 > balance Sheet > total Assets
1757000
Annuals > 2 > balance Sheet > payables
603000
Annuals > 2 > balance Sheet > short Term Debt
4492000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
16855000
Annuals > 2 > balance Sheet > equity
-15098000
Annuals > 2 > cash Flow > net Income
-7581897
Annuals > 2 > cash Flow > depreciation
179037
Annuals > 2 > cash Flow > change In Working Capital
756689
Annuals > 2 > cash Flow > cash From Operations
-5477352
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
2250000
Annuals > 2 > cash Flow > net Change In Cash
-3227352
Annuals > 2 > ratios > PE
-0.5788061523841935
Annuals > 2 > ratios > PB
-0.3464419947079083
Annuals > 2 > ratios > ROE
50.2185719962909
Annuals > 2 > ratios > ROA
-431.5310187820148
Annuals > 2 > ratios > FCF
-5477352
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
8013722
Annuals > 3 > income Statement > operating Income
-8013722
Annuals > 3 > income Statement > interest Expense
16767
Annuals > 3 > income Statement > pretax Income
-7895600
Annuals > 3 > income Statement > net Income
-7892991
Annuals > 3 > income Statement > eps
-0.6025470524285239
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
13099377
Annuals > 3 > income Statement > income Tax Expense
-2609
Annuals > 3 > income Statement > EBITDA
-8013722
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
118122
Annuals > 3 > balance Sheet > cash
4539229
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
51262
Annuals > 3 > balance Sheet > inventories
70444
Annuals > 3 > balance Sheet > total Current Assets
4730217
Annuals > 3 > balance Sheet > property Plant Equipment
318126
Annuals > 3 > balance Sheet > total Assets
5216081
Annuals > 3 > balance Sheet > payables
172508
Annuals > 3 > balance Sheet > short Term Debt
2199105
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
13900185
Annuals > 3 > balance Sheet > equity
-8684104
Annuals > 3 > cash Flow > net Income
-7895600
Annuals > 3 > cash Flow > depreciation
236558
Annuals > 3 > cash Flow > change In Working Capital
176801
Annuals > 3 > cash Flow > cash From Operations
-6826863
Annuals > 3 > cash Flow > capital Expenditures
3
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
2049999
Annuals > 3 > cash Flow > net Change In Cash
-4776863
Annuals > 3 > ratios > PE
-0.6025470524285239
Annuals > 3 > ratios > PB
-0.6023167428787126
Annuals > 3 > ratios > ROE
90.89010219131414
Annuals > 3 > ratios > ROA
-151.32033033996214
Annuals > 3 > ratios > FCF
-6826866
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.14156150341178594
Valuation > metrics > PB
1.227917236222653
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-36.984214898919966
Profitability > metrics > ROA
-32.62887857317371
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.32719468291332043
Risk > metrics > Interest Coverage
-1
Risk > final Score
56
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.773177842565597
Liquidity > metrics > Quick Ratio
4.773177842565597
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
39.395520695970696
Prev Valuations > 1
20
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-34
Prev Risks > 1
-283
Prev Risks > 2
68
Prev Liquidities > 0
100
Prev Liquidities > 1
76
Prev Liquidities > 2
100
Updated At
2025-12-14T00:40:47.632Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-12
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.06
Earnings History > 0 > eps Difference
0.06
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-07
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.06
Earnings History > 1 > eps Estimate
-0.06
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
0
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-07
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.13
Earnings History > 2 > eps Estimate
-0.16
Earnings History > 2 > eps Difference
0.03
Earnings History > 2 > surprise Percent
18.75
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-13
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.22
Earnings History > 3 > eps Estimate
-0.18
Earnings History > 3 > eps Difference
-0.04
Earnings History > 3 > surprise Percent
-22.2222
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-13
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-1.17
Earnings History > 4 > eps Estimate
-0.22
Earnings History > 4 > eps Difference
-0.95
Earnings History > 4 > surprise Percent
-431.8182
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-13
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.25
Earnings History > 5 > eps Estimate
-0.305
Earnings History > 5 > eps Difference
0.055
Earnings History > 5 > surprise Percent
18.0328
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-09
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.36
Earnings History > 6 > eps Estimate
-0.32
Earnings History > 6 > eps Difference
-0.04
Earnings History > 6 > surprise Percent
-12.5
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-09
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.34
Earnings History > 7 > eps Estimate
-0.34
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
0
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-14
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.2314
Earnings History > 8 > eps Estimate
-0.18
Earnings History > 8 > eps Difference
-0.0514
Earnings History > 8 > surprise Percent
-28.5556
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-13
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.17
Earnings History > 9 > eps Estimate
-0.09
Earnings History > 9 > eps Difference
-0.08
Earnings History > 9 > surprise Percent
-88.8889
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-14
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-1.43
Earnings History > 10 > eps Estimate
-0.4
Earnings History > 10 > eps Difference
-1.03
Earnings History > 10 > surprise Percent
-257.5
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-06-30
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.39
Earnings History > 11 > eps Estimate
-0.39
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2021-09-30
Earnings History > 12 > report Date
2021-10-28
Earnings History > 12 > date
2021-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.24
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.24
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2021-06-30
Earnings History > 13 > report Date
2021-09-20
Earnings History > 13 > date
2021-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.49
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.49
Earnings History > 13 > surprise Percent
-
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAll You Need to Know About Intensity Therapeutics Inc. (INTS) Rating Upgrade to Buy - Nasdaq
12/15/2025
All You Need to Know About Intensity Therapeutics Inc. (INTS) Rating Upgrade to Buy Nasdaq
Read more →Aug Chart Watch: Can INTS stock surprise with earnings upside - Options Play & AI Driven Stock Price Forecasts moha.gov.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$2.9167
Analyst Picks
Strong Buy
1
Buy
2
Hold
2
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 2.35% of the total shares of Intensity Therapeutics, Inc. Common stock
1.
Sentinus, LLC(0.4236%)
since
2025/06/30
2.
Brown Advisory Holdings Inc(0.2764%)
since
2025/06/30
3.
Mesirow Fin Investmt Mgmt Intl Equity(0.2338%)
since
2025/06/30
4.
Geode Capital Management, LLC(0.1547%)
since
2025/06/30
5.
Sigma Planning Corp(0.147%)
since
2025/06/30
6.
Warberg Asset Management LLC(0.1454%)
since
2025/06/30
7.
Jane Street Group LLC(0.0954%)
since
2025/06/30
8.
Fidelity Extended Market Index(0.0918%)
since
2025/07/31
9.
Vanguard Group Inc(0.0862%)
since
2025/06/30
10.
Blair William & Co(0.0803%)
since
2025/06/30
11.
One Charles Private Wealth Services, LLC(0.0676%)
since
2025/06/30
12.
Vanguard Institutional Extnd Mkt Idx Tr(0.0593%)
since
2025/07/31
13.
HRT FINANCIAL LLC(0.0529%)
since
2025/06/30
14.
XTX Topco Ltd(0.0522%)
since
2025/06/30
15.
QTR Family Wealth, LLC(0.037%)
since
2025/06/30
16.
Stonebridge Financial Group, LLC(0.0351%)
since
2025/06/30
17.
EWA, LLC(0.0341%)
since
2025/06/30
18.
BOOTHBAY FUND MANAGEMENT, LLC(0.0319%)
since
2025/06/30
19.
State Street Corp(0.0308%)
since
2025/06/30
20.
Northern Trust Corp(0.0298%)
since
2025/06/30
21.
Virtu Financial LLC(0.0291%)
since
2025/06/30
22.
Tower Research Capital LLC(0.0287%)
since
2025/06/30
23.
Fidelity Series Total Market Index(0.0227%)
since
2025/07/31
24.
Fidelity Total Market Index(0.02%)
since
2025/07/31
25.
NT Ext Equity Mkt Idx Fd - L(0.0166%)
since
2025/06/30
26.
Northern Trust Extended Eq Market Idx(0.0166%)
since
2025/06/30
27.
Fidelity Nasdaq Composite Index(0.0147%)
since
2025/07/31
28.
NT Ext Equity Mkt Idx Fd - NL(0.0127%)
since
2025/06/30
29.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0098%)
since
2025/06/30
30.
Spartan Total Market Index Pool G(0.0055%)
since
2025/07/31
31.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0047%)
since
2025/06/30
32.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0017%)
since
2024/12/31
33.
Northern Trust Wilshire 5000(0.0005%)
since
2025/06/30
34.
Fidelity U.S. Equity Index Ins Trust(0%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.06
Date
2025-09-30
EPS Actual
-0.06
EPS Estimate
-0.06
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.